COMBINED IV IRON AND ULTRA LOW-DOSE ERYTHROPOIETIN (RHUEPO) THERAPY IN HEMODIALYSIS-PATIENTS

被引：0
|
作者：
TSOBANELIS, T
HOPPE, D
SCIGALLA, P
GRUTZMACHER, P
机构：
[1] ST MARKUS HOSP,MED CLIN 2,FRANKFURT,GERMANY
[2] BOEHRINGER MANNHEIM GMBH,W-6800 MANNHEIM 31,GERMANY
来源：
KIDNEY INTERNATIONAL | 1992年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [41] KETOGENIC EFFECTS OF LOW-DOSE L-CARNITINE SUPPLEMENTATION IN HEMODIALYSIS-PATIENTS
    WANNER, C
    WIELAND, H
    WACKERLE, B
    BOECKLE, H
    SCHOLLMEYER, P
    HORL, WH
    KIDNEY INTERNATIONAL, 1989, 36 : S304 - S304
  • [42] ORAL IRON-ABSORPTION IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN
    DONNELLY, SM
    POSEN, GA
    ALI, MAM
    CLINICAL AND INVESTIGATIVE MEDICINE, 1991, 14 (04): : 271 - 276
  • [43] KINETICS AND BALANCE OF IRON IN ANEMIC PATIENTS ON HEMODIALYSIS SUBJECTED TO TREATMENT WITH ERYTHROPOIETIN (RHUEPO)
    NUNEZ, J
    DEIRA, J
    GASCON, A
    LERMA, JL
    TABERNERO, JM
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 577 - 578
  • [44] IRON THERAPY IN HEMODIALYSIS-PATIENTS - TIME FOR A REAPPRAISAL
    HUMAN, LE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04): : 371 - 371
  • [45] ASSESSMENT OF THE EFFICACY OF CONSTANT LOW-DOSES OF RHUEPO IN HEMODIALYSIS-PATIENTS - IRON-METABOLISM AND SECONDARY EFFECTS
    BOLANOS, L
    MESA, L
    VAZQUEZ, C
    LAVILLA, J
    ERRASTI, P
    PURROY, A
    NEFROLOGIA, 1992, 12 : 37 - 42
  • [46] LOW-DOSE ASPIRIN DOES NOT PREVENT THROMBOVASCULAR ACCIDENTS IN LOW-RISK HEMODIALYSIS-PATIENTS DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    KOOISTRA, MP
    VANES, A
    MARX, JJM
    HERTSIG, MLA
    STRUYVENBERG, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1115 - 1120
  • [47] EFFECT OF ERYTHROPOIETIN THERAPY ON DIET AND DIALYSIS CLEARANCES IN HEMODIALYSIS-PATIENTS
    KAUPKE, CJ
    VAZIRI, ND
    SAMPSON, JR
    ATKINS, K
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (04): : 218 - 222
  • [48] Usefulness of intravenous iron supplement during recombinant human erythropoietin (rHuEPO) therapy in hemodialysis (HD) patients.
    Park, KJ
    Kang, JY
    Yang, WS
    Kim, SB
    Park, JS
    Hong, CD
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1799 - 1799
  • [49] Prospective randomised comparison of three routes of iron administration during erythropoietin (rHuEPO) therapy in hemodialysis patients.
    Lye, WC
    Chin, S
    Wong, KC
    Fan, KS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1018 - A1018
  • [50] LONG-TERM ERYTHROPOIETIN THERAPY FOR ANEMIA IN HEMODIALYSIS-PATIENTS
    MUIRHEAD, N
    WONG, C
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 312 - 312
12345